Guardant Health dips after unveiling $500 mln convertible offering

By Reuters News

** Shares of precision oncology firm Guardant Health GH.O fall 2.6% to $150.74 in extended trading as it looks to raise capital

** Palo Alto, California-based GH offering privately $500 mln convertible bonds (CBs) due May 15, 2032

** Co expects to use net offering proceeds to repurchase a portion of its 0% CBs due 2027, remainder for general corp purposes, including potential acquisitions

** Also, GH intends to use some proceeds to fund cost of capped calls, transactions employed to mitigate potential dilution

** GH has about $21 bln market cap

** Stock closed down 0.4% at $154.78 on Weds, trimming YTD gain to 51.5%

** 26 of 28 analysts rate the stock "strong buy" or "buy", 2 "hold"; median PT is $200, per LSEG data

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.

The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.

To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.

Any information which could be construed as “investment research” has not been prepared in accordance with legal requirements designed to promote the independence of investment research and as such is considered to be a marketing communication.